A comparison of anatomical and dosimetric variations in the first 15 fractions, and between fractions 16 and 25, of intensity-modulated radiotherapy for nasopharyngeal carcinoma

被引:0
作者
Yang, Haihua [1 ,2 ]
Tu, Yu [3 ]
Wang, Wei [1 ,2 ]
Hu, Wei [1 ,2 ]
Ding, Weijun [1 ,2 ]
Yu, Changhui [1 ,2 ]
Zhou, Chao [1 ,2 ]
机构
[1] Taizhou Hosp, Dept Radiat Oncol, Wenzhou Med Coll, Taizhou 317000, Zhejiang, Peoples R China
[2] Taizhou Hosp, Lab Cellular & Mol Radiat Oncol, Wenzhou Med Coll, Taizhou 317000, Zhejiang, Peoples R China
[3] Soochow Univ, Sch Radiat Med & Protect, Coll Med, Jiangsu Prov Key Lab Radiat Med & Protect, Suzhou, Jiansu, Peoples R China
来源
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS | 2013年 / 14卷 / 06期
关键词
replans; nasopharyngeal carcinoma; intensity-modulated radiotherapy; DEFORMABLE IMAGE REGISTRATION; NECK-CANCER; RADIATION-THERAPY; PAROTID-GLANDS; GEOMETRIC CHANGES; HEAD; IMRT; CHEMORADIOTHERAPY; STRATEGIES; SHRINKAGE;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to compare anatomical and dosimetric variations in first 15 fractions, and between fractions 16 and 25, during intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC). Twenty-three NPC patients who received IMRT in 33 fractions were enrolled. Each patient had two repeat computed tomography (CT) scans before the 16th and 25th fraction. Hybrid IMRT plans were generated to evaluate the dosimetric changes. There was a significant decrease of the transverse diameter of nasopharyngeal and neck as well as gross tumor volume (GTV) in the primary nasopharyngeal carcinoma (GTVnx) and involved lymph nodes (GTVnd) during the first 15 fractions, and between fraction 16 and 25 (p < 0.05). Consequently, there was a significant reduction of the percentage of the volume receiving the prescribed dose (V-100) of CTV1 and GTVnd, which was more prominent after the first 15 fractions treatment compared to that between fraction 16 and 25 (p < 0.05). Additionally, there was a significant increase in the mean dose (Dmean) and percentage of volume receiving >= 30 Gy (V-30) to the bilateral parotid in the first 15 fractions (p < 0.05), but not between fraction 16 and 25. While the maximum dose to the spinal cord was significantly increased both in the first 15 fractions, and between fraction 16 and 25 (p < 0.05), the increase of the percent of spinal cord volume receiving >= 40 Gy (V-40) was significantly higher in the first 15 fractions compared to that between fraction 16 and 25 (p < 0.05). Based on the dose constraint criterion in the RTOG0225 protocol, a total 39.1% (9/23) of phantom plan 1 (generated by applying the beam configurations of the original IMRT treatment plan to the anatomy of the second CT scan) and 17.4% (4/23) of phantom 2 (generated by applying the beam configurations of the replan 1 to the anatomy of the third CT scan) were out of limit for the dose to the normal critical structures. In conclusion, our data indicated that anatomic changes resulted in more predominant dosimetric effects in the first 15 fractions, and between fractions 16 and 25, of IMRT.
引用
收藏
页码:27 / 39
页数:13
相关论文
共 50 条
  • [21] Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Chua, DTT
    Sham, JST
    Leung, LHT
    Au, GKH
    RADIOTHERAPY AND ONCOLOGY, 2005, 77 (03) : 290 - 294
  • [22] Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer
    Lu, Jia-Yang
    Cheung, Michael Lok-Man
    Li, Mei
    Huang, Bao-Tian
    Xie, Wen-Jia
    Xie, Liang-Xi
    PLOS ONE, 2015, 10 (07):
  • [23] CLINICAL STUDY OF THE NECESSITY OF REPLANNING BEFORE THE 25TH FRACTION DURING THE COURSE OF INTENSITY-MODULATED RADIOTHERAPY FOR PATIENTS WITH NASOPHARYNGEAL CARCINOMA
    Wang, We
    Yang, Haihua
    Hu, Wei
    Shan, Guoping
    Ding, Weijun
    Yu, Changhui
    Wang, Biyun
    Wang, Xufeng
    Xu, Qianyi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 617 - 621
  • [24] Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Xia, P
    Fu, KK
    Wong, GW
    Akazawa, C
    Verhey, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 329 - 337
  • [25] Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
    Lyu, Yingchen
    Ni, Mengshan
    Zhai, Ruiping
    Kong, Fangfang
    Du, Chengrun
    Hu, Chaosu
    Ying, Hongmei
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (07) : 2549 - 2557
  • [26] Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
    Songthong, Anussara
    Chakkabat, Chakkapong
    Kannarunimit, Danita
    Lertbutsayanukul, Chawalit
    RADIOLOGY AND ONCOLOGY, 2015, 49 (02) : 155 - 162
  • [27] A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma
    Xu, Yumei
    Shao, Zhiying
    Tang, Tianyou
    Liu, Guihong
    Yao, Yuanhu
    Wang, Jianshe
    Zhang, Longzhen
    ONCOLOGY LETTERS, 2018, 16 (05) : 6126 - 6132
  • [28] Intensity-modulated radiotherapy, volume-modulated arc therapy and helical tomotherapy for locally advanced nasopharyngeal carcinoma: a dosimetric comparison
    Chen, Wen
    Yang, Xiaoyu
    Jiang, Nian
    Zhang, Zijian
    Hong, Jidong
    He, Yuxiang
    Luo, Junli
    Liang, Ying
    Wei, Rui
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 929 - 939
  • [29] Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
    Aftab, Omer
    Liao, Shufang
    Zhang, Rongjun
    Tang, Nan
    Luo, Meiqing
    Zhang, Bin
    Shahi, Sanjeev
    Rai, Raju
    Ali, Jazib
    Jiang, Wei
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [30] Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
    Xue, Fen
    Niu, Xiaoshuang
    Hu, Chaosu
    He, Xiayun
    FRONTIERS IN ONCOLOGY, 2022, 12